Literature DB >> 29772831

Human Chorionic Gonadotropin (hCG)-An Endocrine, Regulator of Gestation and Cancer.

Helene Heidegger1, Udo Jeschke2.   

Abstract

Human Chorionic Gonadotropin (hCG) is a heterodimeric glycoprotein composed of two subunits [...].

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29772831      PMCID: PMC5983709          DOI: 10.3390/ijms19051502

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


Human Chorionic Gonadotropin (hCG) is a heterodimeric glycoprotein composed of two subunits [1]. This important and very complex molecule, that exists in different molecular forms, is implicated in all major reproductive and developmental processes in humans [1,2]. Although the title implies that hCG is an endocrine regulator, we are aware that hCG actions during pregnancy (except luteal regulation) and in cancers are largely paracrine and/or autocrine in nature. In the last years, the significance and the importance of hCG have really expanded, and many studies suggest an important role of this glycoprotein in the field of pregnancy. hCG is secreted by the syncytiotrophoblast which originates from fused and differentiated cytotrophoblast cells [3,4]. For a long time, the main known role of hCG was the promotion of progesterone secretion by the corpus luteum in early pregnancy, acting via the hCG/LH (luteinizing hormone) receptor. However, more recently, many other functions of hCG, not only in the placenta but also in the myometrium, the uterus, and the fetus, have been described [5,6,7]. In addition, the LH/hCG receptor is also expressed on granulosa cells. Casarini et al. have reported that the signaling pathways of hCG and LH do not completely overlap, and this fact may have implications for hCG use in assisted reproductive techniques (ART) [8]. Hershko Klement et al. described that a gonadotropin-releasing hormone (GnRH) agonist, initially presented as a substitute for hCG, has led to a new era of administering a GnRH agonist followed by hCG triggering [9]. hCG promotes angiogenesis and vascular genesis in the uterine vasculature during pregnancy [10,11], whereas its role in placental growth and development is incontrovertible. The hCG/LH receptor was also found in fetal organs, and thus it is suggested that hCG plays an important role in organ growth and differentiation in the fetus [12,13,14]. A function for hCG in umbilical cord growth and development has also been reported in the literature [15]. Many additional different immunomodulatory effects of hCG are described [16,17,18]. Schumacher et al. found that hCG determines fetal fate by regulating maternal innate and adaptive immune responses, allowing the acceptance of the foreign fetal antigens [19]. Environmental pollution can disturb hCG function during pregnancy. Paulescu et al. showed that prenatal exposure to selected endocrine-disrupting chemicals like Bisphenol A can have a deleterious impact on the fetus and long-lasting consequences also in adult life [2]. Some new data have shown a function of hCG in the implantation process [20,21]. Makrigiannakis et al. showed that hCG is one of the key molecules during the process of implantation. hCG effectively modulates several metabolic pathways within the decidua, contributing to endometrial receptivity [22]. In addition, the hCG/LH receptor has also been identified in adults women’s brain, a finding that could explain the hyperemesis gravidarum during pregnancy [23]. The expression of hCG is observed in several types of malignancies, including prostate cancer [24], colorectal cancer [25], lung adenocarcinoma [26], and different gynecological cancers, such as endometrial adenocarcinoma, breast cancer [27], cervical carcinoma [28], and ovarian cancer [29], and is associated with especially poorly differentiated and high-grade tumors [30]. Human chorionic gonadotrophin may be also a possible mediator of leiomyoma growth during pregnancy [31]. Finally, Theofanakis et al. showed that hCG could have a potential role as an anti-rejection agent in solid organ transplantation [32]. In summary, hCG is a multifaceted hormone with a very wide range of actions. In this Special Issue, “hCG—An Endocrine, Regulator of Gestation and Cancer” we have tried to highlight the different functional aspects of hCG and give a promising insight into different pathophysiological aspects, clinical applications, and therapeutic options related to hCG.
  32 in total

1.  beta hCG as a prognostic marker in adenocarcinoma of the prostate.

Authors:  M T Sheaff; J E Martin; D F Badenoch; S I Baithun
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 2.  Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation?

Authors:  S Perrier d'Hauterive; S Berndt; M Tsampalas; C Charlet-Renard; M Dubois; C Bourgain; A Hazout; J-M Foidart; V Geenen
Journal:  Gynecol Obstet Invest       Date:  2007-10-04       Impact factor: 2.031

3.  Upregulation of placental indoleamine 2,3-dioxygenase by human chorionic gonadotropin.

Authors:  Z M Lei; M Yang; X Li; O Takikawa; C V Rao
Journal:  Biol Reprod       Date:  2006-12-20       Impact factor: 4.285

4.  Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain.

Authors:  Z M Lei; C V Rao; J L Kornyei; P Licht; E S Hiatt
Journal:  Endocrinology       Date:  1993-05       Impact factor: 4.736

5.  Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance.

Authors:  Anne Schumacher; Kristina Heinze; Jeanette Witte; Eileen Poloski; Nadja Linzke; Katja Woidacki; Ana C Zenclussen
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

Review 6.  The importance of hCG in human endometrial adenocarcinoma and breast cancer.

Authors:  Alexandra C Kölbl; Kristina Schlenk; Nils Behrendt; Ulrich Andergassen
Journal:  Int J Biol Markers       Date:  2018-01       Impact factor: 2.659

Review 7.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

Review 8.  hCG: Biological Functions and Clinical Applications.

Authors:  Chinedu Nwabuobi; Sefa Arlier; Frederick Schatz; Ozlem Guzeloglu-Kayisli; Charles Joseph Lockwood; Umit Ali Kayisli
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

9.  Estrogen Modulates Specific Life and Death Signals Induced by LH and hCG in Human Primary Granulosa Cells In Vitro.

Authors:  Livio Casarini; Laura Riccetti; Francesco De Pascali; Lisa Gilioli; Marco Marino; Eugenia Vecchi; Daria Morini; Alessia Nicoli; Giovanni Battista La Sala; Manuela Simoni
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

Review 10.  Human Chorionic Gonadotropin: The Pregnancy Hormone and More.

Authors:  Charalampos Theofanakis; Petros Drakakis; Alexandros Besharat; Dimitrios Loutradis
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

View more
  3 in total

1.  Follicular development and the expression of BAX and vascular endothelial growth factor in transplanted ovaries in uni- and bilateral ovariectomized mice: An experimental study.

Authors:  Maryam Dehghan; Shirin Shahbazi; Mojdeh Salehnia
Journal:  Int J Reprod Biomed       Date:  2021-04-22

2.  Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol.

Authors:  Xiuzhen Shen; Qinjie Yang; Lanfang Li; Wenhao Lu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

3.  A first trimester prediction model for large for gestational age infants: a preliminary study.

Authors:  Francesca Monari; Daniela Menichini; Ludovica Spano' Bascio; Giovanni Grandi; Federico Banchelli; Isabella Neri; Roberto D'Amico; Fabio Facchinetti
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-24       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.